PTPRC and metastatic prostate carcinoma: We frequently found TRA + cells with a mean CD45 intensity below 0.3 AU in metastatic prostate cancer patients (Figure 4B, red) as well as in the patient who progressed from localized to metastatic prostate cancer during the study (Figure 4B, orange).